Michael Boice

547 total citations
6 papers, 237 citations indexed

About

Michael Boice is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Michael Boice has authored 6 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Cancer Research and 1 paper in Organic Chemistry. Recurrent topics in Michael Boice's work include RNA Interference and Gene Delivery (3 papers), MicroRNA in disease regulation (3 papers) and Redox biology and oxidative stress (2 papers). Michael Boice is often cited by papers focused on RNA Interference and Gene Delivery (3 papers), MicroRNA in disease regulation (3 papers) and Redox biology and oxidative stress (2 papers). Michael Boice collaborates with scholars based in United States, Belgium and United Kingdom. Michael Boice's co-authors include Pieter Rondou, Joni Van der Meulen, Pieter Van Vlierberghe, Tom Taghon, Yves Benoît, Steven Goossens, Nadine Van Roy, Jo Vandesompele, Frank Speleman and Bruce Poppe and has published in prestigious journals such as The Journal of Experimental Medicine, Leukemia and Science Signaling.

In The Last Decade

Michael Boice

6 papers receiving 235 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Boice United States	5	173	132	37	33	28	6	237
Daniela Soriano Pignataro United States	9	205 1.2×	55 0.4×	17 0.5×	38 1.2×	44 1.6×	13	281
Zhongxin Zheng China	7	233 1.3×	158 1.2×	9 0.2×	26 0.8×	61 2.2×	19	275
Manuel Boix-Chornet Spain	7	289 1.7×	31 0.2×	18 0.5×	57 1.7×	42 1.5×	7	357
Alexandra Schurer United States	6	250 1.4×	106 0.8×	8 0.2×	43 1.3×	64 2.3×	11	319
Emma Baron Italy	6	268 1.5×	115 0.9×	10 0.3×	107 3.2×	50 1.8×	7	328
Hisashi Kurata Japan	6	138 0.8×	69 0.5×	10 0.3×	38 1.2×	17 0.6×	11	244
Xabi Agirre Spain	4	305 1.8×	250 1.9×	11 0.3×	22 0.7×	38 1.4×	4	386
Courtney L. Andersen United States	8	144 0.8×	40 0.3×	13 0.4×	69 2.1×	15 0.5×	17	290
Alena Maljukova Sweden	2	153 0.9×	24 0.2×	27 0.7×	87 2.6×	23 0.8×	2	188
Anna Polak Poland	8	113 0.7×	35 0.3×	19 0.5×	70 2.1×	23 0.8×	26	239

Countries citing papers authored by Michael Boice

Since Specialization

Citations

This map shows the geographic impact of Michael Boice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Boice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Boice more than expected).

Fields of papers citing papers by Michael Boice

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Boice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Boice. The network helps show where Michael Boice may publish in the future.

Co-authorship network of co-authors of Michael Boice

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Boice. A scholar is included among the top collaborators of Michael Boice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Boice. Michael Boice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Mets, Evelien, Gert Van Peer, Joni Van der Meulen, et al.. (2014). MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia. Haematologica. 99(8). 1326–1333. 52 indexed citations

2.

Mets, Evelien, Joni Van der Meulen, Gert Van Peer, et al.. (2014). MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia. Leukemia. 29(4). 798–806. 88 indexed citations

3.

Oricchio, Elisa, Giovanni Ciriello, Man Jiang, et al.. (2014). Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy. The Journal of Experimental Medicine. 211(7). 1379–1391. 23 indexed citations

4.

Sanghvi, Viraj R., Konstantinos J. Mavrakis, Joni Van der Meulen, et al.. (2014). Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia. Science Signaling. 7(352). ra111–ra111. 34 indexed citations

5.

Baker, Amanda F., Natarajan Raghunand, Helen Chow, et al.. (2012). A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers. Investigational New Drugs. 31(3). 631–641. 38 indexed citations

6.

Kirkpatrick, David, et al.. (2008). 108 POSTER Screening Plasma Thioredoxin-1 (Trx-1) to potentially guide clinical development of the Trx-1 Inhibitor PX-12. European Journal of Cancer Supplements. 6(12). 36–36. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact